These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34295309)

  • 1. Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas.
    Rai A; Das L; Mukherjee KK; Dhandapani S; Tripathi M; Ahuja CK; Radotra BD; Dutta P
    Front Endocrinol (Lausanne); 2021; 12():708111. PubMed ID: 34295309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased β‑catenin and c-myc expression predict aggressive growth of non-functioning pituitary adenomas: An assessment using a tissue microarray-based approach.
    Liu C; Wu Y; Yu S; Bai J; Li C; Wu D; Zhang Y
    Mol Med Rep; 2017 Apr; 15(4):1793-1799. PubMed ID: 28260015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
    Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.
    Batista RL; Trarbach EB; Marques MD; Cescato VA; da Silva GO; Herkenhoff CGB; Cunha-Neto MB; Musolino NR
    World Neurosurg; 2018 Dec; 120():e241-e246. PubMed ID: 30138730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natural history study of postoperative residual non-functioning pituitary adenomas].
    Wu ZB; Chen Y; Lü QP; Wang CD; Su ZP; Wu JS; Zheng WM; Zhuge QC
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(9):597-600. PubMed ID: 20450781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the Recurrence of Non-Functioning Pituitary Adenomas Using Preoperative Supra-Intra Sellar Volume and Tumor-Carotid Distance.
    Chen W; Wang M; Duan C; Yao S; Jiao H; Wang Z; Hu B; Mao Z; Zhu Y; Wang H
    Front Endocrinol (Lausanne); 2021; 12():748997. PubMed ID: 34659129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis.
    Galland F; Lacroix L; Saulnier P; Dessen P; Meduri G; Bernier M; Gaillard S; Guibourdenche J; Fournier T; Evain-Brion D; Bidart JM; Chanson P
    Endocr Relat Cancer; 2010 Jun; 17(2):361-71. PubMed ID: 20228124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Positive Staining of Non-Functioning Pituitary Adenomas for Luteinizing Hormone Associated with a Poor Prognosis?
    Diri H; Ozaslan E; Kurtsoy A; Tucer B; Simsek Y; Ozturk F; Durak AC; Erten S; Bayram F
    Turk Neurosurg; 2017; 27(1):8-13. PubMed ID: 27593756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Invasive-Related Biomarker in Three Subtypes of Nonfunctioning Pituitary Adenomas.
    Chen Y; Chuan HL; Yu SY; Li CZ; Wu ZB; Li GL; Zhang YZ
    World Neurosurg; 2017 Apr; 100():514-521. PubMed ID: 28093347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in CD8
    Huang X; Xu J; Wu Y; Sheng L; Li Y; Zha B; Sun T; Yang J; Zang S; Liu J
    Pathol Oncol Res; 2021; 27():598887. PubMed ID: 34257554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
    Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
    World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate assessment of estrogen receptor profiles in non-functioning pituitary adenomas using RT-digital PCR and immunohistochemistry.
    Hattori Y; Ishii H; Tahara S; Morita A; Ozawa H
    Life Sci; 2020 Nov; 260():118416. PubMed ID: 32926922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen Receptor α, a Sex-Dependent Predictor of Aggressiveness in Nonfunctioning Pituitary Adenomas: SSTR and Sex Hormone Receptor Distribution in NFPA.
    Øystese KA; Casar-Borota O; Normann KR; Zucknick M; Berg JP; Bollerslev J
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3581-3590. PubMed ID: 28911153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI texture analysis as a predictor of tumor recurrence or progression in patients with clinically non-functioning pituitary adenomas.
    Galm BP; Martinez-Salazar EL; Swearingen B; Torriani M; Klibanski A; Bredella MA; Tritos NA
    Eur J Endocrinol; 2018 Sep; 179(3):191-198. PubMed ID: 29973377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of TGF-β RII expression is correlated with tumor growth and invasion in non-functioning pituitary adenomas.
    Gu YH; Feng YG
    J Clin Neurosci; 2018 Jan; 47():264-268. PubMed ID: 29031543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
    Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
    Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the World Health Organization definition of atypia on surgically treated functional and non-functional pituitary adenomas.
    Sarkar S; Philip VJ; Cherukuri SK; Chacko AG; Chacko G
    Acta Neurochir (Wien); 2017 Nov; 159(11):2179-2186. PubMed ID: 28573325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ultra-low-field intraoperative magnetic resonance imaging on extent of resection and frequency of tumor recurrence in 104 surgically treated nonfunctioning pituitary adenomas.
    Hlavica M; Bellut D; Lemm D; Schmid C; Bernays RL
    World Neurosurg; 2013 Jan; 79(1):99-109. PubMed ID: 23043996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of EpCAM and Trop2 in pituitary adenomas.
    Chen X; Pang B; Liang Y; Xu SC; Xin T; Fan HT; Yu YB; Pang Q
    Int J Clin Exp Pathol; 2014; 7(11):7907-14. PubMed ID: 25550831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
    Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
    Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.